BMS 182874 hydrochloride

CAS No. 1215703-04-0

BMS 182874 hydrochloride( —— )

Catalog No. M23383 CAS No. 1215703-04-0

BMS 182874 hydrochloride is a nonpeptide endothelin (El) receptor antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 227 In Stock
10MG 340 In Stock
25MG 572 In Stock
50MG 797 In Stock
100MG 1107 In Stock
500MG 2223 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BMS 182874 hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    BMS 182874 hydrochloride is a nonpeptide endothelin (El) receptor antagonist.
  • Description
    BMS 182874 hydrochloride is a nonpeptide endothelin (El) receptor antagonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Endothelin Receptor
  • Recptor
    ET-A
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1215703-04-0
  • Formula Weight
    381.88
  • Molecular Formula
    C17H20ClN3O3S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:100mM
  • SMILES
    CC1=C(NS(=O)(C2=CC=CC3=C2C=CC=C3N(C)C)=O)ON=C1C.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.MARIA L WEBB, J. EILEEN BIRD, EDDIE C. K. LIU, PATRICIA M. ROSE, RANDY SERAFINO, PHILIP D. STEIN and SUZANNE MORELAND. BMS-182874 is a selective, nonpeptide endothelin ETA receptor antagonist. JPET 272:1124-1134, 1995.
molnova catalog
related products
  • BQ-788

    BQ-788 is a selective and potent ETB receptor antagonist with potential hypertensive activity.BQ-788 inhibits ET-1 binding to ETB receptors and inhibits exogenous ET-1-induced elevation of coronary artery perfusion pressure.

  • SB-209670

    SB-209670 is a selective endothelin receptor antagonist that inhibits the activity of ET(B) receptors in rat vascular endothelium and vascular smooth muscle.

  • Edonentan

    Edonentan is A potent endothelin A (ETA) receptor antagonist that can be used to study heart failure.